The Nifty Pharma index is trading at a price-to-earnings multiple of 31, lower than its five-year average of 36. Fund managers bought into stocks like Aurobindo Pharma, Cipla, Pfizer, Lupin, JB Chemicals, Alkem, and Syngene International.
| Subscribe To Our Free Newsletter |
